Kinoxis Therapeutics Pty Ltd
Kinoxis Therapeutics is an Australian-based clinical-stage biotechnology company developing therapeutics for neuropsychiatric disorders.
- Headquarters
- Melbourne, Victoria, AustraliaSource: RevenueBaseRetrieved October 13, 2026
- Employee range
- 1 to 10Source: RevenueBaseRetrieved October 13, 2026
- Founded
- 2017Source: RevenueBaseRetrieved October 13, 2026
- Published list appearances
- 5 supported appearances ↗Source: RevenueBase lists
What does Kinoxis Therapeutics Pty Ltd do?
The company is developing KNX100 to treat behavioural and psychological symptoms in neuropsychiatric disorders, including agitation and aggression in dementia and several substance use disorders. KNX100 is being investigated in a multi-site Phase 2 study in Australia, examining its safety, tolerability and efficacy for agitation in dementia.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Company lists.
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Share your recognition
Embeddable award for your website
Sources & data notes.
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 15, 2026, September 18, 2026 and September 19, 2026. How the company lists are built.
Something changed?
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
One company is just the start.
Explore more companies by name, headquarters and business focus.